Cargando…

Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology

PURPOSE: To explore top-ranked plasma proteins related to neovascular age-related macular degeneration (AMD) and geographic atrophy (GA), and explore pathways related to neovascular AMD and GA. METHODS: We conducted a pilot study of patients with neovascular AMD (n = 10), GA (n = 10), and age-matche...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Anne M., Wagner, Brandie D., Weiss, Sophie J., Wall, Kirsten M., Palestine, Alan G., Mathias, Marc T., Siringo, Frank S., Cathcart, Jennifer N., Patnaik, Jennifer L., Drolet, Daniel W., Janjic, Nebojsa, Mandava, Naresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348995/
https://www.ncbi.nlm.nih.gov/pubmed/30697465
http://dx.doi.org/10.1167/tvst.8.1.14
_version_ 1783390208533725184
author Lynch, Anne M.
Wagner, Brandie D.
Weiss, Sophie J.
Wall, Kirsten M.
Palestine, Alan G.
Mathias, Marc T.
Siringo, Frank S.
Cathcart, Jennifer N.
Patnaik, Jennifer L.
Drolet, Daniel W.
Janjic, Nebojsa
Mandava, Naresh
author_facet Lynch, Anne M.
Wagner, Brandie D.
Weiss, Sophie J.
Wall, Kirsten M.
Palestine, Alan G.
Mathias, Marc T.
Siringo, Frank S.
Cathcart, Jennifer N.
Patnaik, Jennifer L.
Drolet, Daniel W.
Janjic, Nebojsa
Mandava, Naresh
author_sort Lynch, Anne M.
collection PubMed
description PURPOSE: To explore top-ranked plasma proteins related to neovascular age-related macular degeneration (AMD) and geographic atrophy (GA), and explore pathways related to neovascular AMD and GA. METHODS: We conducted a pilot study of patients with neovascular AMD (n = 10), GA (n = 10), and age-matched cataract controls (n = 10) who were recruited into an AMD registry. We measured 4001 proteins in ethylenediaminetetraacetic acid plasma samples using an aptamer-based proteomic technology. Relative concentrations of each of 4001 proteins were log (base 2) transformed and compared between cases of neovascular AMD and GA versus controls using linear regression. Pathway analysis was conducted using pathways downloaded from Reactome. RESULTS: In this pilot study, higher levels of vinculin and lower levels of CD177 were found in patients with neovascular AMD compared with controls. Neuregulin-4 was higher and soluble intercellular adhesion molecule-1 was lower in patients with GA compared with controls. For neovascular AMD, cargo trafficking to the periciliary membrane, fibroblast growth factor receptor 3b ligand binding and activation, and vascular endothelial growth factor–related pathways were in the top ranked pathways. The top-ranked pathways for GA included several related to ErbB4 signaling. CONCLUSIONS: We found different proteins and different pathways associated with neovascular AMD and GA. Vinculin and some of the top-ranked pathways have been previously associated with AMD, whereas others have not been described. TRANSLATIONAL RELEVANCE: Biomarkers identified in plasma likely reflect systemic alterations in protein expression and may improve our understanding of the mechanisms leading to AMD.
format Online
Article
Text
id pubmed-6348995
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-63489952019-01-29 Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology Lynch, Anne M. Wagner, Brandie D. Weiss, Sophie J. Wall, Kirsten M. Palestine, Alan G. Mathias, Marc T. Siringo, Frank S. Cathcart, Jennifer N. Patnaik, Jennifer L. Drolet, Daniel W. Janjic, Nebojsa Mandava, Naresh Transl Vis Sci Technol Articles PURPOSE: To explore top-ranked plasma proteins related to neovascular age-related macular degeneration (AMD) and geographic atrophy (GA), and explore pathways related to neovascular AMD and GA. METHODS: We conducted a pilot study of patients with neovascular AMD (n = 10), GA (n = 10), and age-matched cataract controls (n = 10) who were recruited into an AMD registry. We measured 4001 proteins in ethylenediaminetetraacetic acid plasma samples using an aptamer-based proteomic technology. Relative concentrations of each of 4001 proteins were log (base 2) transformed and compared between cases of neovascular AMD and GA versus controls using linear regression. Pathway analysis was conducted using pathways downloaded from Reactome. RESULTS: In this pilot study, higher levels of vinculin and lower levels of CD177 were found in patients with neovascular AMD compared with controls. Neuregulin-4 was higher and soluble intercellular adhesion molecule-1 was lower in patients with GA compared with controls. For neovascular AMD, cargo trafficking to the periciliary membrane, fibroblast growth factor receptor 3b ligand binding and activation, and vascular endothelial growth factor–related pathways were in the top ranked pathways. The top-ranked pathways for GA included several related to ErbB4 signaling. CONCLUSIONS: We found different proteins and different pathways associated with neovascular AMD and GA. Vinculin and some of the top-ranked pathways have been previously associated with AMD, whereas others have not been described. TRANSLATIONAL RELEVANCE: Biomarkers identified in plasma likely reflect systemic alterations in protein expression and may improve our understanding of the mechanisms leading to AMD. The Association for Research in Vision and Ophthalmology 2019-01-25 /pmc/articles/PMC6348995/ /pubmed/30697465 http://dx.doi.org/10.1167/tvst.8.1.14 Text en Copyright 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Articles
Lynch, Anne M.
Wagner, Brandie D.
Weiss, Sophie J.
Wall, Kirsten M.
Palestine, Alan G.
Mathias, Marc T.
Siringo, Frank S.
Cathcart, Jennifer N.
Patnaik, Jennifer L.
Drolet, Daniel W.
Janjic, Nebojsa
Mandava, Naresh
Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
title Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
title_full Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
title_fullStr Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
title_full_unstemmed Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
title_short Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
title_sort proteomic profiles in advanced age-related macular degeneration using an aptamer-based proteomic technology
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348995/
https://www.ncbi.nlm.nih.gov/pubmed/30697465
http://dx.doi.org/10.1167/tvst.8.1.14
work_keys_str_mv AT lynchannem proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT wagnerbrandied proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT weisssophiej proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT wallkirstenm proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT palestinealang proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT mathiasmarct proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT siringofranks proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT cathcartjennifern proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT patnaikjenniferl proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT droletdanielw proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT janjicnebojsa proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology
AT mandavanaresh proteomicprofilesinadvancedagerelatedmaculardegenerationusinganaptamerbasedproteomictechnology